SEC Form 4 · accession 0002079962-26-000013
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick A Mayes
Officer — EVP & Chief Scientific Officer
Period of report
Jul 31, 2026
Accepted (ET)
Aug 4, 2026 · 4:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2026 | M | 2,918 | $61.18 | A | 66,546 | D | |
| Common Stock | Jul 31, 2026 | M | 2,284 | $64.25 | A | 68,830 | D | |
| Common Stock | Jul 31, 2026 | M | 2,709 | $61.76 | A | 71,539 | D | |
| Common Stock | Jul 31, 2026 | M | 3,148 | $68.62 | A | 74,687 | D | |
| Common Stock | Jul 31, 2026 | M | 2,072 | $71.93 | A | 76,759 | D | |
| Common Stock | Jul 31, 2026 | M | 9,459 | $72.27 | A | 86,218 | D | |
| Common Stock | Jul 31, 2026 | M | 2,623 | $74.78 | A | 88,841 | D | |
| Common Stock | Jul 31, 2026 | M | 2,864 | $77.67 | A | 91,705 | D | |
| Common Stock | Jul 31, 2026 | M | 1,643 | $80.50 | A | 93,348 | D | |
| Common Stock | Jul 31, 2026 | M | 3,023 | $83.20 | A | 96,371 | D | |
| Common Stock | Jul 31, 2026 | M | 2,623 | $83.58 | A | 98,994 | D | |
| Common Stock | Jul 31, 2026 | M | 1,642 | $85.01 | A | 100,636 | D | |
| Common Stock | Jul 31, 2026 | M | 2,293 | $90.56 | A | 102,929 | D | |
| Common Stock | Jul 31, 2026 | M | 85 | $106.47 | A | 103,014 | D | |
| Common Stock | Jul 31, 2026 | M | 326 | $105.43 | A | 103,340 | D | |
| Common Stock | Jul 31, 2026 | S | 14,661 | $119.46 | D | 88,679 | D | |
| Common Stock | Jul 31, 2026 | S | 5,332 | $119.42 | D | 83,347 | D | |
| Common Stock | Jul 31, 2026 | S | 2,187 | $119.47 | D | 81,160 | D | |
| Common Stock | Jul 31, 2026 | S | 6,171 | $119.43 | D | 74,989 | D | |
| Common Stock | Jul 31, 2026 | S | 4,695 | $119.39 | D | 70,294 | D | |
| Common Stock | Jul 31, 2026 | S | 2,864 | $119.40 | D | 67,430 | D | |
| Common Stock | Jul 31, 2026 | S | 1,643 | $119.51 | D | 65,787 | D | |
| Common Stock | Jul 31, 2026 | S | 1,642 | $119.38 | D | 64,145 | D | |
| Common Stock | Jul 31, 2026 | S | 85 | $122.19 | D | 64,060 | D | |
| Common Stock | Jul 31, 2026 | S | 326 | $121.69 | D | 63,734 | D | |
| Common Stock | Jul 31, 2026 | S | 2,293 | $119.41 | D | 61,441 | D | |
| Common Stock | Aug 3, 2026 | M | 6,055 | $105.43 | A | 67,496 | D | |
| Common StockF1 | Aug 3, 2026 | S | 6,055 | $120.43 | D | 61,441 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $61.18 | Jul 31, 2026 | M | 2,918 | D | — | Jan 17, 2034 | Common Stock | 2,918 | 1,328 | D |
| Employee Stock Option (right to buy)F3 | $64.25 | Jul 31, 2026 | M | 2,284 | D | — | Jul 14, 2034 | Common Stock | 2,284 | 2,938 | D |
| Employee Stock Option (right to buy)F4 | $61.76 | Jul 31, 2026 | M | 2,709 | D | — | Jul 13, 2033 | Common Stock | 2,709 | 1,233 | D |
| Employee Stock Option (right to buy)F5 | $68.62 | Jul 31, 2026 | M | 3,148 | D | — | Jul 1, 2028 | Common Stock | 3,148 | 0 | D |
| Employee Stock Option (right to buy)F6 | $71.93 | Jul 31, 2026 | M | 2,072 | D | — | Jan 16, 2035 | Common Stock | 2,072 | 2,665 | D |
| Employee Stock Option (right to buy)F5 | $72.27 | Jul 31, 2026 | M | 9,459 | D | — | Jan 3, 2029 | Common Stock | 9,459 | 0 | D |
| Employee Stock Option (right to buy)F5 | $74.78 | Jul 31, 2026 | M | 2,623 | D | — | Jan 18, 2032 | Common Stock | 2,623 | 0 | D |
| Employee Stock Option (right to buy)F5 | $77.67 | Jul 31, 2026 | M | 2,864 | D | — | Jul 1, 2032 | Common Stock | 2,864 | 191 | D |
| Employee Stock Option (right to buy)F5 | $80.50 | Jul 31, 2026 | M | 1,643 | D | — | Jan 16, 2030 | Common Stock | 1,643 | 0 | D |
| Employee Stock Option (right to buy)F5 | $83.20 | Jul 31, 2026 | M | 3,023 | D | — | Jan 19, 2033 | Common Stock | 3,023 | 202 | D |
| Employee Stock Option (right to buy)F5 | $83.58 | Jul 31, 2026 | M | 2,623 | D | — | Jul 1, 2031 | Common Stock | 2,623 | 0 | D |
| Employee Stock Option (right to buy)F5 | $85.01 | Jul 31, 2026 | M | 1,642 | D | — | Jul 1, 2029 | Common Stock | 1,642 | 0 | D |
| Employee Stock Option (right to buy)F5 | $90.56 | Jul 31, 2026 | M | 2,293 | D | — | Jan 14, 2031 | Common Stock | 2,293 | 0 | D |
| Employee Stock Option (right to buy)F5 | $106.47 | Jul 31, 2026 | M | 85 | D | — | Jul 1, 2030 | Common Stock | 85 | 2,207 | D |
| Employee Stock Option (right to buy)F5 | $105.43 | Jul 31, 2026 | M | 326 | D | — | Nov 6, 2027 | Common Stock | 326 | 6,055 | D |
| Employee Stock Option (right to buy)F5 | $105.43 | Aug 3, 2026 | M | 6,055 | D | — | Nov 6, 2027 | Common Stock | 6,055 | 0 | D |
Explanation of responses
- F1This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.
- F2Options granted on January 18, 2024 and will vest monthly through July 14, 2027
- F3Options granted on July 15, 2024 and will vest monthly through July 15, 2028
- F4Options granted on July 14, 2023 and will vest monthly through July 14, 2027
- F5As of July 31st, 2026, the award is fully vested and exercisable.
- F6Options granted on January 17, 2025 and will vest monthly through July 15, 2028